Summary by Moomoo AI
Kangfang Biotechnology (Cayman) Co., Ltd. (“Kangfang Biotech” or the “Company”) issued a notice on 29 April 2024 announcing that its 2023 report has been issued. The report is available in Chinese and English and can be accessed on the website of the Hong Kong Stock Exchange Limited (“HKEx”) and on the official website of Kangfang Biotech. In compliance with the paperless listing mechanism and electronic company communications regulations effective December 31, 2023, the Company has adopted the electronic publication of its corporate communications, including Directors' Reports, Annual Accounts, Audit Reports, Interim Reports, Meeting Notices, etc. Shareholders who experience difficulties in accessing or receiving electronic communications may request the Company to obtain a free printed copy. In addition, the Company requests that shareholders provide an e-mail address for sending corporate communications that require action. Shareholders may provide an email address via the QR code on the return bar, or elect to receive the company's correspondence in printed form, subject to reconfirmation within one year of the instruction.